Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
31.2M
-
Shares change
-
+7.87M
-
Total reported value, excl. options
-
$150M
-
Value change
-
+$47.7M
-
Put/Call ratio
-
1.8
-
Number of buys
-
94
-
Number of sells
-
-31
-
Price
-
$4.80
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2024
145 filings reported holding HUMA - Humacyte, Inc. - COM as of Q2 2024.
Humacyte, Inc. - COM (HUMA) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2M shares
.
Largest 10 shareholders include BlackRock Inc. (7.14M shares), VANGUARD GROUP INC (4.73M shares), STATE STREET CORP (2.87M shares), GEODE CAPITAL MANAGEMENT, LLC (1.86M shares), MILLENNIUM MANAGEMENT LLC (1.6M shares), Nuveen Asset Management, LLC (1.24M shares), TWO SIGMA INVESTMENTS, LP (1.14M shares), GOLDMAN SACHS GROUP INC (762K shares), VOLORIDGE INVESTMENT MANAGEMENT, LLC (687K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (654K shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.